Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mesoblast Ltd ADR (NQ: MESO ) 7.230 +0.130 (+1.83%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mesoblast Ltd ADR < Previous 1 2 3 4 5 6 Next > 36 Stocks Moving In Wednesday's Mid-Day Session December 15, 2021 Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 15, 2021 Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday December 15, 2021 We're at the halfway point of the week but there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday! Via InvestorPlace 20 Stocks Moving in Wednesday's Pre-Market Session December 15, 2021 Gainers Galera Therapeutics, Inc. (NASDAQ: GRTX) rose 17.7% to $3.18 in pre-market trading after BTIG upgraded the stock from Neutral to Buy and announced a $15 price target.... Via Benzinga 50 Biggest Movers From Yesterday December 15, 2021 Gainers Sidus Space, Inc. (NASDAQ: SIDU) shares jumped 143.8% to settle at $12.19 on Tuesday after the company priced its IPO at $5 per share, MIND Technology, Inc. (NASDAQ: MIND... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session December 14, 2021 Gainers Galera Therapeutics (NASDAQ:GRTX Via Benzinga 34 Stocks Moving In Tuesday's Mid-Day Session December 14, 2021 Gainers Exicure, Inc. (NASDAQ: XCUR) rose 41.8% to $0.3830. Exicure’s Audit Committee recently concluded that Grant Corbett misreported raw data from certain R&D... Via Benzinga Why Mesoblast Shares Are Falling December 14, 2021 Mesoblast Limited (NASDAQ: MESO) shares are trading lower after the company was notified by Novartis that it has chosen to terminate the agreement with Mesoblast prior to... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 14, 2021 Gainers Galera Therapeutics (NASDAQ:GRTX) stock increased by 134.05% to $3.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $... Via Benzinga Mesoblast's Heart Failure Candidate Shows Treatment Benefit In High-Risk Patients December 06, 2021 Mesoblast Limited (NASDAQ: MESO) announced new analyses from the landmark DREAM-HF Phase 3 trial of rexlemestrocel-L in HFrEF patients with diabetes and/or ischemia... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session December 03, 2021 Gainers Lixte Biotech Holdings (NASDAQ:LIXT Via Benzinga Mesoblast Announces Debt Refinancing And Expansion With Oaktree Capital November 22, 2021 Mesoblast Limited (NASDAQ: MESO) refinanced its existing senior debt facility with a new $90 million five-year facility provided by Oaktree Capital Management... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 15, 2021 Gainers Tricida (NASDAQ:TCDA) shares rose... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session November 15, 2021 Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is... Via Benzinga Mesoblast's Remestemcel Shows Promising Action In Patients With Heart Failure November 15, 2021 Mesoblast Limited (NASDAQ: MESO) presented new results from the landmark Phase 3 study of rexlemestrocel-L in 565 patients with chronic heart failure (CHF) with... Via Benzinga The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data September 21, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs October 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal October 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... Via Benzinga The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab September 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... Via Benzinga Exposures COVID-19 Product Safety 38 Stocks Moving In Wednesday's Mid-Day Session September 01, 2021 Gainers Focus Universal Inc. (NASDAQ: FCUV) shares jumped 108.2% to $10.62. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands Group, Inc. (NASDAQ:... Via Benzinga 54 Biggest Movers From Yesterday September 02, 2021 Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session September 01, 2021 Gainers GBS (NASDAQ:GBS) stock moved upwards by 51.23% to $4.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $60.6 million... Via Benzinga The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering September 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... Via Benzinga 21 Stocks Moving in Wednesday's Pre-Market Session September 01, 2021 Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-... Via Benzinga 55 Biggest Movers From Yesterday September 01, 2021 Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it... Via Benzinga Why Mesoblast Stock Is Plunging After Q4 Earnings Report? August 31, 2021 Mesoblast Limited (NASDAQ: MESO) shares dived on Tuesday as the FDA raised more questions around its flagship drug candidate, and its annual loss widened. ... Via Benzinga Exposures Product Safety 33 Stocks Moving In Tuesday's Mid-Day Session August 31, 2021 Gainers AC Immune SA (NASDAQ: ACIU) shares jumped 68.4% to $11.77. AC Immune and its collaborating partner Genentech, part of Roche Holdings, announced topline data from Phase 2... Via Benzinga Mesoblast (MESO) Q3 2021 Earnings Call Transcript August 31, 2021 MESO earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Mesoblast Shares 90-Day Survival Outcomes After Remestemcel-L From COVID-19 ARDS Trial July 19, 2021 Mesoblast Limited (NASDAQ: MESO) has announced the presentation of 90-day survival outcomes from the remestemcel-L trial in ventilator-dependent COVID-19 patients... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.